MSB Trading 2020 - a new dawn, page-171

That picture of the child with AGVHD was freaking heartbreaking.

With the safety proven, and those survival rates versus mortality rates without Rem-L (numbers not lying, telling a clear, consistent tale, particularly vis-a-vis the improvements derived from the optimisation of Rem-L), any parent on that AdComm is going to have a seriously hard time justifying a vote that Rem-L is not efficacious.

I have long loved this company, but I am bursting my buttons with pride over them after reading those slidedecks (yes, I know they are preaching to the converted...).

Really wish MSB all the best, here's to all of the wee kiddywinkies and their parents that are going to be saved the horrible pain of suffering of AGVHD when this groundbreaking therapy is approved and Rem-L is made readily and easily available.

GO, MSB!!